Primary Tumor Volume, Bulky Adenopathy, and Number (But Not Location) of Involved Nodal Stations Predict Outcome in N2-N3 NSCLC Treated With Definitive Chemoradiation Therapy

@inproceedings{Miller2014PrimaryTV,
  title={Primary Tumor Volume, Bulky Adenopathy, and Number (But Not Location) of Involved Nodal Stations Predict Outcome in N2-N3 NSCLC Treated With Definitive Chemoradiation Therapy},
  author={Lance C. Miller and Sudeep Garg and Marta Batus and Philip Bonomi and Mary Jo Fidler and Julius V. Turian and David J Sher},
  year={2014}
}